Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DocCheck AGFRA:AJ91 +0.87%71 Pretax Margin % is 15.25% as of Dec. 2025, which is 4% above its 10-year median of 14.68. GuruFocus rates FRA:AJ91 with a GF Score™ of 71/100 and a GF Value™ of €9.28 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 664 Healthcare Providers & Services companies, DocCheck AG ranks better than 82.23% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. DocCheck AG's Pre-Tax Income for the
six
months ended in Dec. 2025 was €4.39 Mil. DocCheck AG's Revenue for the
six
months ended in Dec. 2025 was €28.77 Mil. Therefore, DocCheck AG's pretax margin for the quarter that ended in Dec. 2025 was 15.25%.
The historical rank and industry rank for DocCheck AG's Pretax Margin % or its related term are showing as below:
FRA:AJ91'
s Pretax Margin % Range Over the Past 10 Years
Min: 8.21 Med: 14.68 Max: 21.97
Current: 15.09
FRA:AJ91's Pretax Margin % is ranked better than 82.23% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 4.02
vs FRA:AJ91: 15.09
DocCheck AG (FRA:AJ91) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
DocCheck AG Pretax Margin % Related Terms
DocCheck AG Pretax Margin % Historical Data
* Premium members only.
The historical data trend for DocCheck AG's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:AJ91 vs VEEV, BTSG, TEM: Pretax Margin % Comparison
For the Health Information Services subindustry, DocCheck AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocCheck AG Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocCheck AG's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where DocCheck AG's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocCheck AG (FRA:AJ91) has a Pretax Margin % of 15.25% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on DocCheck AG and its competitors. This is near median its historical median of 14.68. Over the past decade, DocCheck AG's Pretax Margin % has ranged from 8.21 to 21.97. According to the industry distribution chart, DocCheck AG ranks #118 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 17.8%.
Is DocCheck AG's Pretax Margin % too high?
DocCheck AG's current Pretax Margin % of 15.25% is near median its 10-year median of 14.68. Over the past 10 years, this metric has ranged from a low of 8.21 to a high of 21.97. The Healthcare Providers & Services industry median Pretax Margin % is 4.02. DocCheck AG's value of 15.25% is 279.4% above this industry median. Based on the distribution chart, DocCheck AG ranks #118 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DocCheck AG has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DocCheck AG's Pretax Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DocCheck AG ranks #118 out of 664 companies for Pretax Margin %. This places DocCheck AG in the top 18% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 4.02. DocCheck AG's value of 15.25% is 279.4% above this benchmark. Historically, DocCheck AG's own Pretax Margin % has ranged from 8.21 to 21.97 over the past decade. While the company's 10-year median is 14.68 vs. the industry median of 4.02, DocCheck AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.02, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocCheck AG's current Pretax Margin % of 15.25% is 279.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on DocCheck AG and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocCheck AG's current Pretax Margin % is 15.25%, which is near median its own 10-year median of 14.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocCheck AG stock overvalued right now?
Based on GuruFocus' analysis, DocCheck AG (FRA:AJ91) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.28, compared to a current price of €11.60 — trading 25% above its estimated fair value. The current Pretax Margin % is 15.25%, which is near median its 10-year median of 14.68 and 279.4% above the Healthcare Providers & Services industry median of 4.02. DocCheck AG's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For DocCheck AG (FRA:AJ91), the current Pretax Margin % is 15.25% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocCheck AG (FRA:AJ91) Overvalued in 2026?
Based on GuruFocus' analysis, DocCheck AG stock appears to be overvalued.
The current stock price of €11.60 is trading 25% above its estimated GF Value™ of €9.28.
GuruFocus considers DocCheck AG to be Modestly Overvalued.
Key valuation signals for FRA:AJ91:
Pretax Margin %: 15.25% (near median its 10-year median of 14.68)
GF Value™: €9.28 vs. price of €11.60 (25% above fair value)
Industry Position: 279.4% above the Healthcare Providers & Services median (#118 of 664)
No single metric tells the full story. See the FRA:AJ91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
71GF Score
Get the complete analysis for FRA:AJ91
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AJ91 has been successfully added to your 
